BioMarin Pharmaceutical (NASDAQ:BMRN)

biotech

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

There should be no surprise to biotech investors that the mergers and acquisition (M&A) market and chatter are heating up. The huge buy of Synageva Biopharma Corp. (NASDAQ: GEVA) by ...
Read Full Story »
Biotechnology word cloud

Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks

Combine the upcoming typical summer weakness with howls of a biotech bubble, and the recipe is in place for trouble, even for the top stocks in the industry. In a ...
Read Full Story »
Biotechnology word cloud

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

The XBI, which is the S&P 500 biotech index, has been hit hard this week and is down almost 14% since last Friday. While still up big over the past ...
Read Full Story »
Euro

How the Weaker Euro Is Impacting Biotech Earnings

It is no secret that a strong dollar and a weak euro, and foreign currency environment, are acting to hurt U.S. corporate earnings. Many investors might think that biotech earnings ...
Read Full Story »
Pills

The Next 3 Likely Biotech Buyout Candidates

One good way for a company to increase sales and move past simple organic growth is to make an acquisition, and that is just what AbbVie Inc. (NYSE: ABBV) did ...
Read Full Story »
uncertainty market evolution

Cowen Raises Price Targets on Top Momentum Stocks

As the market continues its march higher, investors are starting to look for the stocks that are delivering results or data that can drive share prices higher. After an almost ...
Read Full Story »
Pills

Why 1 Analyst Sees Over 50% Upside in Sarepta

Sarepta Therapeutics Inc. (NASDAQ: SRPT) received a favorable rating from Merrill Lynch, and as a result the stock was climbing in Tuesday’s trading session. The firm raised its rating to ...
Read Full Story »
research

Analyst Sees BioMarin Up Another 25%

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) received a favorable analyst call from Merrill Lynch in Monday’s trading session. The brokerage firm reinstated a Buy rating for the stock with a $117 ...
Read Full Story »
Biotechnology word cloud

Portfolio Managers Love These 5 Biotech Stocks

If there is one industry that had a busy January, it was biotech. In fact, January set an all-time record for issuance and funds raised in the biotech sector, and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, ADM, BofA, Chesapeake, Google, J.P. Morgan, MGM and More

Stocks were staging a second major bounce on Thursday after a big gain on Wednesday. Investors just keep proving over and over that they are buyers of stocks on weakness ...
Read Full Story »
Biotechnology word cloud

Wells Fargo’s Top Biotech Stocks for 2015

Looking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo ...
Read Full Story »
biotech

The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers

The bull market is nearing six years old. It turns out that the biotech sector again managed a huge outperforming year in 2014 as well. The gains of the key ...
Read Full Story »
research

RBC’s 5 Top Biotech Stocks to Buy for 2015

As the year 2014 heads toward the finish line, many of the top Wall Street firms are sharpening their pencils and getting top ideas that make good sense for 2015 out ...
Read Full Story »
biotech

RBC Has Three Top Biotech Picks for Year End and 2015

If any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the spring and in the fall has given some biotech investors ...
Read Full Story »
Ebola Virus

Big News for Ebola Stocks

Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but don't tell that to the Ebola drug stocks. NewLink Genetics Corp. (NASDAQ: ...
Read Full Story »